Background
Dr. New is the director of the Sickle Cell Disease Program in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. She joined the hospital staff in 2023.
She was previously a hematologist-oncologist at Children’s Healthcare of Atlanta, where she most recently served as director of Diversity, Equity and Inclusion and clinical director of the Egleston Sickle Cell Program in the Aflac Cancer and Blood Disorders Center. Before that she was the Egleston hospital’s section chief of hematology-oncology and clinical director in the Aflac Cancer and Blood Disorders Center in Egleston. She was also associate professor of pediatrics at Emory Pediatric Institute.
Dr. New has published numerous peer-reviewed articles and book chapters and has given many talks internationally, nationally and regionally. Her research interests include recruitment for multi-center trials in sickle cell, as well as global initiatives in sickle cell disease service, education and awareness.
Dr. New earned her medical degree from Mount Sinai School of Medicine in New York. She completed her pediatric internship and residency at University of Medicine and Dentistry of New Jersey-Robert Wood Johnson University Hospital in New Brunswick, New Jersey. She then completed a fellowship in pediatric hematology-oncology at Columbia University/New York Presbyterian Medical Center.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.